<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=GLUCAGON</id>
	<title>GLUCAGON - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.crsguidelines.org/index.php?action=history&amp;feed=atom&amp;title=GLUCAGON"/>
	<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=GLUCAGON&amp;action=history"/>
	<updated>2026-04-20T15:29:48Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.37.2</generator>
	<entry>
		<id>https://www.crsguidelines.org/index.php?title=GLUCAGON&amp;diff=114&amp;oldid=prev</id>
		<title>Cgabryszek: Created page with &quot;&#039;&#039;&#039;Class&#039;&#039;&#039;  Hormone (antihypoglycemic agent)  &#039;&#039;&#039;Pharmacology and Actions&#039;&#039;&#039;  # Increases blood sugar concentration by converting liver glycogen to glucose. # Relaxes smooth muscle of the GI tract. # Increases heart rate and cardiac contractility.  &#039;&#039;&#039;Indications&#039;&#039;&#039;  # Symptomatic hypoglycemia when IV access is unsuccessful. # Hypotensiion from beta-blocker or calcium channel blocker overdose unresponsive to normal saline bolus. # Suspected symptomatic esophageal foreig...&quot;</title>
		<link rel="alternate" type="text/html" href="https://www.crsguidelines.org/index.php?title=GLUCAGON&amp;diff=114&amp;oldid=prev"/>
		<updated>2022-04-04T03:38:41Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&amp;#039;&amp;#039;&amp;#039;Class&amp;#039;&amp;#039;&amp;#039;  Hormone (antihypoglycemic agent)  &amp;#039;&amp;#039;&amp;#039;Pharmacology and Actions&amp;#039;&amp;#039;&amp;#039;  # Increases blood sugar concentration by converting liver glycogen to glucose. # Relaxes smooth muscle of the GI tract. # Increases heart rate and cardiac contractility.  &amp;#039;&amp;#039;&amp;#039;Indications&amp;#039;&amp;#039;&amp;#039;  # Symptomatic hypoglycemia when IV access is unsuccessful. # Hypotensiion from beta-blocker or calcium channel blocker overdose unresponsive to normal saline bolus. # Suspected symptomatic esophageal foreig...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Class&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
Hormone (antihypoglycemic agent)&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Pharmacology and Actions&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Increases blood sugar concentration by converting liver glycogen to glucose.&lt;br /&gt;
# Relaxes smooth muscle of the GI tract.&lt;br /&gt;
# Increases heart rate and cardiac contractility.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Indications&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Symptomatic hypoglycemia when IV access is unsuccessful.&lt;br /&gt;
# Hypotensiion from beta-blocker or calcium channel blocker overdose unresponsive to normal saline bolus.&lt;br /&gt;
# Suspected symptomatic esophageal foreign body.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Contraindications&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Hypersensitivity to the drug&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Precautions&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Use with caution in patients with a history of cardiovascular disease, renal disease, pheochromocytoma or insulinoma.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Administration&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Hypoglycemia: Adult dose; 1 mg IM&lt;br /&gt;
# Beta blocker / Ca ++ Channel Blocker OD - Contact medical control&lt;br /&gt;
## Adult Dose: 2mg IV/IO&lt;br /&gt;
## Pediatric Dose: 0.1 mg/kg IV/IO (max dose is 1 mg).&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Side Effects and Special Notes&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
# Nausea, vomiting, and headache.&lt;br /&gt;
# When glucagon is given for hypoglycemia the patient should receive glucose as soon as possible after the administration of glucagon.&lt;/div&gt;</summary>
		<author><name>Cgabryszek</name></author>
	</entry>
</feed>